A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

New sleep medication





Press Announcements FDA approves new type of sleep drug

10/19/2014
03:05 | Author: Kate Thompson

New sleep medication
Press Announcements FDA approves new type of sleep drug

The U.S. Food and Drug Administration today approved Belsomra (suvorexant) tablets for use as needed to treat difficulty in falling and staying.

Belsomra is a controlled substance (Schedule-IV) because it can be abused or lead to dependence. Belsomra will be dispensed with an FDA-approved patient Medication Guide that provides instructions for its use and important safety information.

The total dose should not exceed 20 mg once daily. Belsomra should be taken no more than once per night, within 30 minutes of going to bed, with at least seven hours remaining before the planned time of waking.

“To assist health care professionals and patients in finding the best dose to treat each individual patient’s sleeplessness, the FDA has approved Belsomra in four different strengths – 5, 10, 15, and 20 milligrams,” said Ellis Unger, M.D., director of the Office of Drug Evaluation I in the FDA’s Center for Drug Evaluation and Research.

Comments (1)Read more



Groundbreaking sleeping pill may put insomnia issues to bed - CBS

8/18/2014
01:30 | Author: Caitlin White

New sleep medication
Groundbreaking sleeping pill may put insomnia issues to bed - CBS

But a new type of sleeping pill may offer some hope. On Wednesday the FDA approved "Belsorma," a new drug from Merck & Co., which will be.

"This is an exciting new drug," Ash said. "It really is a new tool and toolkit for the treatment of insomnia.".

2014 CBS Interactive Inc.

Ash says that while the drug is more focused than existing insomnia medications, it still has similar side effects like daytime drowsiness and headaches.

"Usually sleeping drugs are a knockout punch to the brain; they knock out circuits throughout the brain," Ash said. This drug is like a switch that actually turns off the lights.". "Think of a house where you get a surge and the electricity goes off for the refrigerator, the TV, not just the lights.

It specifically targets brain chemicals that keep you awake, and speeds the onset of sleep.

Comments (2)Read more

FDA approves new sleeping drug from Merck Daily Mail Online

6/17/2014
01:55 | Author: Kate Thompson

New sleep medication
FDA approves new sleeping drug from Merck Daily Mail Online

Controversial new sleeping drug designed to allow people who suffer patients who get the new drug receive a medication guide detailing the.

Like other prescription sleeping drugs, Belsomra is designed to be taken only once per night and only when patients have at least seven hours before they need to wake up.

The Food and Drug Administration approved the drug Wednesday in four different doses for various degrees of insomnia.

Belsomra is first the first of a new class of drugs. Popular: Sleeping pills such as Ambien and Lunesta are non-diazepine hypnotics.

Comments (3)Read more

FDA approves Belsomra, a new prescription sleep drug - LA Times

4/16/2014
03:40 | Author: Caitlin White

Best sleep medication
FDA approves Belsomra, a new prescription sleep drug - LA Times

The Food & Drug Administration on Wednesday approved U.S. marketing of the first in a new class of sleep drugs that targets the brain's.

Comments (0)

Merck Wins U.S. Approval of New Type of Sleeping Pill - Bloomberg

2/15/2014
05:15 | Author: Kate Thompson

New sleep medication
Merck Wins U.S. Approval of New Type of Sleeping Pill - Bloomberg

Merck & Co., the second-largest U.S. drugmaker, won approval to sell its treatment for insomnia, a new type of drug considered to have fewer.

The company’s shares have increased 19 percent in the past 12 months. Merck gained 1.4 percent to $57.85 at the close in New York.

The drug may generate $305 million in sales in 2017, according to the average of six analysts’ estimates compiled by Bloomberg, down from $516 million forecast before the FDA last year rejected the highest doses as possibly unsafe. The Food and Drug Administration cleared the sleeping pill called Belsomra in lower doses than Whitehouse Station, New Jersey-based Merck originally sought to market, according to a statement yesterday from the agency.

Advertisements.

Comments (5)Read more